Live Breaking News & Updates on Eris lifesciences ltd

Stay informed with the latest breaking news from Eris lifesciences ltd on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Eris lifesciences ltd and stay connected to the pulse of your community

Indian Pharma Market Booms: 9.5% Growth in March 2024

Leading therapies like cardiac, anti-infectives, and gastro-intestinal recorded robust volume growth in MAT figures, constituting 37.5% of IPM.

Alkem-laboratories-ltd , Pfizer-ltd , Eris-lifesciences-ltd , Lupin-ltd , Cipla-ltd , Glaxosmithkline-pharmaceuticals-ltd , Sanofi-india-ltd , Abbott-india-ltd , Alembic-pharma-ltd , Mankind-pharma-ltd , Torrent-pharma-ltd

Biocon Leads India Push Into Weight Loss Drugs as Patents Lapse

Biocon Leads India Push Into Weight Loss Drugs as Patents Lapse
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Bengaluru , Karnataka , India , United-kingdom , Kiran-mazumdar-shaw , Novo-nordisk-ozempic , Eli-lilly , Siddharth-mittal , Peter-bains , Novo-nordisk , Novo-nordisk-to-eli-lilly-co , Sun-pharmaceutical-industries-ltd

Biocon leads India push into weight loss drugs as patents lapse

The Bengaluru-based firm has scored an early win among its peers with the UK approval for the first generic version of liraglutide injectible, which is losing patent protection in November.

Bengaluru , Karnataka , India , United-kingdom , Eli-lilly , Kiran-mazumdar-shaw , Siddharth-mittal , Novo-nordisk-ozempic , Novo-nordisk , Peter-bains , Biocon , Reddy-laboratories-ltd

Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot

Weight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in generic supply. The Bengaluru-based company secured UK approval for the first generic version of liraglutide injectible, positioning itself as a leader in this evolving market.

India , Bengaluru , Karnataka , United-kingdom , Siddharth-mittal , Novo-nordisk , Eli-lilly , Novo-nordisk-ozempic , Kiran-mazumdar-shaw , Peter-bains , Reddy-laboratories-ltd , Biocon

Biocon leads generic race for blockbuster weight loss drugs as patents set to expire soon

Biocon leads generic race for blockbuster weight loss drugs as patents set to expire soon
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

India , United-kingdom , Eli-lilly , Novo-nordisk , Kiran-mazumdar-shaw , Siddharth-mittal , Reddy-laboratories-ltd , Novo-nordisk-to-eli-lilly-co , Bloomberg , Biocon , Eris-lifesciences-ltd , Sun-pharmaceutical-industries-ltd

Generic Weight Loss Drugs Boosted by UK Approval for Biocon

Biocon Ltd. is pivoting to anti-obesity therapies as patents for the blockbuster medications start to expire, unleashing a wave of generic supply for the global weight-loss market that’s expected to touch $100 billion by 2030.

Mumbai , Maharashtra , India , Bengaluru , Karnataka , Huadong , Guangdong , China , United-kingdom , Peter-bains , Novo-nordisk-ozempic , Siddharth-mittal

We will continue to deepen our presence in segments like diabetes through product portfolio expansion: Krishnakumar Vaidyanathan, Executive Director, Eris Lifesciences

We will continue to deepen our presence in segments like diabetes through product portfolio expansion: Krishnakumar Vaidyanathan, Executive Director, Eris Lifesciences
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

India , Krishnakumar-vaidyanathan , Biocon-biologics , World-health-organization , Biocon , Eris-lifesciences-ltd , South-east-asia-region , Indian-pharmaceutical-market , Eris-lifesciences , Financial-express , Executive-director , Chief-operating-officer

Eris Lifesciences acquires 51% in Swiss Parenterals for Rs 637 crore

This deal also marks the entry of Eris into the RoW Export Markets.

India , Australia , Switzerland , United-states , Australian , America , Swiss , Amit-bakshi , Biocon-biologics , Asia-pacific , Eris-lifesciences-ltd , Swiss-parenterals-ltd

Eris Lifesciences acquires 51 percent stake in Swiss Parenterals to expand its footprint in sterile injectables

Eris Lifesciences acquires 51 percent stake in Swiss Parenterals to expand its footprint in sterile injectables
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

United-states , Australia , India , Switzerland , Australian , America , Swiss , Amit-bakshi , Asia-pacific , Promoter-group , Eris-lifesciences-ltd , Swiss-parenterals-ltd

ChrysCapital-backed Eris Life acquires controlling stake in Swiss Parenterals for $77 mn

Listed pharmaceuticals player Eris Lifesciences Ltd has acquired 51% stake in sterile injectables company Swiss Parenterals for Rs 637.5 crore (around $76.7 million), thus foraying ......

India , Ahmedabad , Gujarat , Kuwait , United-states , Bombay , Maharashtra , Mumbai , America , Asia-pacific , Sreeja-biswas , Amit-bakshi